Valuation models
price $273.20 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused221.82 – 392.42284.394% undervaluedDCF · Perpetuity growth · 10y245.27 – 434.38314.6013% undervaluedDCF · EBITDA exit · 5y238.53 – 260.89249.4010% overvaluedDCF · EBITDA exit · 10y260.07 – 306.45282.143% undervaluedP/E · peers154.08 – 298.44255.057% overvaluedP/E · own history231.30 – 278.83252.248% overvaluedPEG—131.10108% overvaluedEV/EBITDA · peers226.32 – 411.15271.86at modelEV/Revenue · peers209.85 – 326.73266.283% overvaluedEarnings power value85.86 – 141.35107.45154% overvaluedDividend discount99.33 – 364.74163.8767% overvaluedWall St. consensus target—280.002% belowCost of capital (WACC)—6.76%—
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
284.39
Johnson & Johnson closed at $273.20 — undervalued by 4% vs model.
221.82the model's range392.42
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
107.45 – 314.60
Wall St. target
280.00 2% below
Below model, 1y
19 of 31 days
How it is valued
Valued asMature & stable
Low/slowing growth (~5% recent)High profitability (28% net margin)Pays dividendsHighly cyclical earnings
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.